Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
146.46
-0.36 (-0.25%)
Streaming Delayed Price
Updated: 2:52 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Johnson & Johnson
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Nearing Retirement? These Stocks Are as Cautious as They Come
February 28, 2024
Healthcare blue chips can provide retirees the consistency they need while growing their nest eggs further.
Via
The Motley Fool
7 Dividend Stocks Every Investor Should Own to Survive a Market Crash
February 27, 2024
Buying dividend stocks for retirement is an excellent way to protect your portfolio in the event of a recession or depression.
Via
InvestorPlace
Topics
Economy
Retirement
Exposures
Economy
Pension
5 Most Owned Dividend Aristocrats® by Top Hedge Funds
February 27, 2024
These five Dividend Aristocrats® all pay safe, reliable, growing dividends.
Via
The Motley Fool
3 Dividend Stocks That Are Too Good to Ignore: Q1 Edition
February 26, 2024
Here are the three dividend stocks that will never disappoint you. Buy them while they trade at a discount.
Via
InvestorPlace
7 Stocks to Buy Now if You Think the S&P 500’s Winning Streak Will Continue
February 25, 2024
S&P 500 is hitting new highs and if you want to make the most of this, buy these S&P 500 stocks.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
Evaluating Johnson & Johnson Against Peers In Pharmaceuticals Industry
February 23, 2024
Via
Benzinga
Is NYSE:JNJ suited for dividend investing?
February 21, 2024
Balancing Dividends and Fundamentals: The Case of JOHNSON & JOHNSON (NYSE:JNJ).
Via
Chartmill
Johnson & Johnson Options Trading: A Deep Dive into Market Sentiment
February 20, 2024
Via
Benzinga
Pension Plan Redux: 3 Companies That Could Take a Page From IBM’s Playbook
February 24, 2024
A new wrinkle from IBM regarding its pension plans could save the company hundreds of millions in future defined contribution payments.
Via
InvestorPlace
3 Undervalued Small-Cap Stocks to Add to Your Must-Buy List
February 22, 2024
Undervalued small-cap stocks are great for investors seeking options for upside potential, typically at a cheap share price.
Via
InvestorPlace
FDA Approves Johnson & Johnson's Reduced Tecvayli Dosing In Pretreated Multiple Myeloma Patients
February 21, 2024
FDA greenlights Johnson & Johnson's Tecvayli for reduced dosing in multiple myeloma patients, achieving complete response for 6+ months.
Via
Benzinga
Exposures
Product Safety
2 Beaten-Down Stocks to Buy and Hold for 10 Years
February 21, 2024
One is a longtime healthcare leader, the other a newcomer; both have bright futures despite recent obstacles.
Via
The Motley Fool
Top 7 Contenders to Join the Trillion-Dollar Club
February 20, 2024
Microsoft's ascent to the $3 trillion mark highlights the growing influence of trillion-dollar companies in the stock market.
Via
InvestorPlace
What the Options Market Tells Us About Johnson & Johnson
February 16, 2024
Via
Benzinga
5 Forever Dividend Stocks to Build Your Portfolio
February 20, 2024
These five stocks are high quality and reliable.
Via
The Motley Fool
Income Lover’s Paradise: 3 Dividend Stocks with Stellar Track Records
February 20, 2024
Over 60 years of annual dividend growth signals that these dividend stocks are quality companies with durable competitive advantages.
Via
InvestorPlace
The Smartest Dividend Stocks to Buy With $400 Right Now
February 19, 2024
These companies will build an ever-growing stream of passive income, one share at a time.
Via
The Motley Fool
Steady Eddies: 3 Blue-Chip Stocks to Buy for the Long Haul
February 18, 2024
AAPL, AB InBev, and Johnson & Johnson are some of the best blue-chip stocks to buy and hold to fortify your investment portfolio.
Via
InvestorPlace
If You Invested $10,000 in Johnson & Johnson Stock in 2004, This Is How Much You Would Have Today
February 18, 2024
Johnson & Johnson has been a stalwart in the healthcare industry for decades, but has it made for a good investment?
Via
The Motley Fool
3 Unstoppable Dividend Stocks That Could Pay You for Life
February 17, 2024
There are no certainties in life or on the stock market. These companies' dividends are about as close as we can get.
Via
The Motley Fool
The 3 Biotech Stocks That Could Make Your February Unforgettable
February 15, 2024
After a blistering hot year of biotech M&A, we’ll see more of the same in 2024. That could be great news for these hot biotech stocks.
Via
InvestorPlace
7 Small-Cap Stocks With Significant Upside Potential in 2024
February 15, 2024
Dive into small-cap stocks for a mix of stability & growth, wagering on potential leaders before the market catches on.
Via
InvestorPlace
Johnson & Johnson to Participate in the Barclays 26th Annual Global Healthcare Conference
February 14, 2024
From
Johnson & Johnson
Via
Business Wire
7 Stable Dividend Stocks to Ease Lingering Market Jitters
February 13, 2024
Although the economic coast seems clear, those who are still unsure can trust in the reliability of stable dividend stocks to buy.
Via
InvestorPlace
3 Dow Stocks You Can Confidently Buy Now and Hold Forever
February 13, 2024
Three highly profitable, time-tested Dow components have the necessary tools to make their patient shareholders notably richer.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
A Look At Pharma ETFs After Q4 Earnings
February 12, 2024
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth.
Via
Talk Markets
Topics
ETFs
Johnson & Johnson to Participate in the Leerink Global Biopharma Conference
February 12, 2024
From
Johnson & Johnson
Via
Business Wire
Is It Too Late to Buy These 2 Brilliant Passive Income Stocks?
February 12, 2024
These incredible businesses have long histories of successes behind them, and more to come.
Via
The Motley Fool
Passive Income Powerhouses: 7 Blue-Chip Stocks to Own Now
February 12, 2024
If you are looking to build wealth through dividend income, here are the passive income blue-chip stocks to buy.
Via
InvestorPlace
DNA Sequencing Kit Provider Illumina's Q4 Earnings Edge Above Street Estimates, Works To Resolve GRAIL Quickly
February 09, 2024
Illumina exceeds Q4 2023 expectations with $1.12 billion sales, up 4% YoY. CEO Jacob Thaysen anticipates growth and outlines strategic priorities for 2024.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.